These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 596978)

  • 1. The effect of quinidine, propranolol and their combination on experimental atrial and ventricular arrhythmias.
    Lawson JH; Wojciechowski NJ
    Arch Int Pharmacodyn Ther; 1977 Oct; 229(2):235-43. PubMed ID: 596978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of quinidine and propranolol in experimental cardiac arrhythmias in the dog.
    Madan BR; Pendse VK
    Arch Int Pharmacodyn Ther; 1977 Feb; 225(2):287-93. PubMed ID: 849075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative antiarrhythmic activity of quinidine combined with propranolol and with sotalol.
    Lawson JW; Wojciechowski NJ
    Arch Int Pharmacodyn Ther; 1981 Jan; 249(1):72-86. PubMed ID: 6111984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of the combination of quinidine and propranolol upon atrial and ventricular automatically in dogs.
    Korte DW; Nash CB
    J Pharmacol Exp Ther; 1978 Feb; 204(2):303-11. PubMed ID: 340642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effect of some antiarrhythmic drugs in right- or left-sided aconitine-induced experimental atrial arrhythmias.
    Gautam CS; Lal R; Pandhi P; Sharma PL
    Methods Find Exp Clin Pharmacol; 1987 Feb; 9(2):91-3. PubMed ID: 3586773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effect of selected antiarrhythmic drugs on coronary artery ligation-induced ventricular arrhythmias on the right or left sides.
    Gautam CS; Sharma PL; Pandhi P
    Methods Find Exp Clin Pharmacol; 1995 Jun; 17(5):327-31. PubMed ID: 8830201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the antiarrhythmic activity of quinidine and quinine.
    Klevans LR; Kelly RJ; Kovacs JL
    Arch Int Pharmacodyn Ther; 1977 May; 227(1):57-68. PubMed ID: 901074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ventricular electrophysiology of quinidine-propranolol combinations in the dog heart.
    Korte DW; Nash CB
    J Pharmacol Exp Ther; 1976 May; 197(2):452-7. PubMed ID: 1271287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arrhythmogenic activities of antiarrhythmic drugs in conscious hypokalemic dogs with atrioventricular block: comparison between quinidine, lidocaine, flecainide, propranolol and sotalol.
    Weissenburger J; Davy JM; Chézalviel F; Ertzbischoff O; Poirier JM; Engel F; Lainée P; Penin E; Motté G; Cheymol G
    J Pharmacol Exp Ther; 1991 Nov; 259(2):871-83. PubMed ID: 1941633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of some beta adrenergic blocking agents and phenytoin on potentiation of quinidine antiarrhythmic activity in the mouse.
    Lawson JW
    Arch Int Pharmacodyn Ther; 1984 Jul; 270(1):106-15. PubMed ID: 6149731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiarrhythmic activity of dextro- and levo-isomers of 5-methyl-8-(2-hydroxy-3-t-butylamino-propoxy) coumarin hydrocholoride (bucumolol), a beta-adrenergic blocking agent, on aconitine-induced atrial and ouabain-induced ventricular arrhythmias in dogs.
    Nakayama K; Oshima T; Koike H
    Jpn J Pharmacol; 1979 Dec; 29(6):935-45. PubMed ID: 44326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of 4 antiarrhythmic drugs on sinoatrial conduction time in isolated and blood-perfused dog atria.
    Shimotori M; Kobayashi M; Chiba S
    Arch Int Pharmacodyn Ther; 1984 Jan; 267(1):67-79. PubMed ID: 6721625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of quinidine-propranolol elevation of the ventricular fibrillation threshold by bilateral stellectomy+vagotomy in the anesthetized dog.
    Lawson JW
    Arch Int Pharmacodyn Ther; 1986 Mar; 280(1):74-83. PubMed ID: 3718083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A microelectrophysiological analysis of the pharmacodynamic basis for quinidine-propranolol antiarrhythmic potentiation.
    Iansmith DH; Bandura JP; Nash CB
    J Pharmacol Exp Ther; 1981 Dec; 219(3):651-8. PubMed ID: 7299688
    [No Abstract]   [Full Text] [Related]  

  • 15. [Experimental anti-arrhythmic effects of a new beta-adrenergic receptor blocking agent, dl-l-(tert. butylamino)-3-[(2-propinyloxy)phenoxy]2-propanol hydrochloride (dl Kö 1400-Cl)].
    Matsubara I; Hashimoto K; Katano Y; Tsukada T; Matsuda H
    Nihon Yakurigaku Zasshi; 1976 Jul; 72(5):557-71. PubMed ID: 11153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A cardiac antiarrhythmic screening test in the rat: the effects of lidocaine, propranolol and quinidine.
    Baker T; Erker EF
    Arch Int Pharmacodyn Ther; 1980 Jan; 243(1):97-102. PubMed ID: 7387264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Combined action of anti-arrhythmia agents].
    Gendenshteĭn EI; Kostin IaV; Balashov VP; Oleĭnikov VE
    Biull Eksp Biol Med; 1991 Jun; 111(6):623-5. PubMed ID: 1893190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of the atrium-specific positive inotropic activities of quinidine- and atropine-like agents in rats.
    Deng XF; Mulay S; Chemtob S; Varma DR
    J Pharmacol Exp Ther; 1997 Apr; 281(1):322-9. PubMed ID: 9103513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative myocardial depressant and anti-arrhythmic properties of d-propranolol, dl-propranolol and quinidine.
    Parmley WW; Braunwald E
    J Pharmacol Exp Ther; 1967 Oct; 158(1):11-21. PubMed ID: 6054071
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of several new antiarrhythmic agents on atrial contractility.
    Covino BG; Shannon CM
    Arch Int Pharmacodyn Ther; 1969 Mar; 178(1):185-92. PubMed ID: 5353470
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.